New cancer Drug's dosing secrets explored in healthy volunteers
Knowledge-focused
Completed
This early-stage study in 28 healthy adults looks at how food and the drug cobicistat change the way plixorafenib (FORE8394) is processed by the body. Participants take single doses under different conditions—fasted, with low-fat or high-fat meals, and with or without cobicistat.…
Phase: PHASE1 • Sponsor: Fore Biotherapeutics • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC